Although currently limited to a primarily adjunctive role, MRI evaluation of cardiac ischemia demonstrates the wide versatility of the modality. Typically, cine images are obtained to evaluate general function and morphology, followed by first-pass perfusion studies (under rest and/or stress), then T1W IR sequences to evaluate myocardial viability. MRI stress testing exploits the fact that extravascular, extracellular gadolinium chelates pass through the myocardial interstitium within minutes of bolus injection, allowing detection of perfusion differences. Within 10 minutes, washout occurs, and a stress-inducing agent and additional contrast may be given. Stress-inducing agents include dobutamine, dipyridamole, or adenosine. The latter two are coronary vasodilators that are contraindicated in obstructive lung disease and necessitate aminophylline administration should angina be induced. In the presence of vascular stenosis, normal vessels are dilated by these agents, such dilatation stealing flow from the distribution of the stenotic vessel. Areas lacking normal perfusion (enhancement) are characterized as fixed (present on both acquisitions) or reversible (present on stress only). Reduced subendocardial perfusion may also represent reversible microvascular disease, severe three-vessel disease with poor reserve, or even artifact. The latter is favored by a deficit of inconsistent size and SI, not localized to a coronary arterial distribution or present only on rest images. Dobutamine increases heart rate and contractility allowing MRI evaluation of wall motion with higher spatial resolution, scan quality, and reproducibility than echocardiography. For wall motion evaluations, cine images are obtained and 17 myocardial segments graded before and after dobutamine in terms of normal wall thickening during systole. Grade 1 constitutes normal wall motion, whereas grades 2, 3, and 4 correlate with hypokinesis, akinesis, and dyskinesis, respectively.
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than that of myocarditis. This pattern is not always reliable, as seen in the patchy, less predominant enhancement in the short axis contrast-enhanced IR T1WI image in Fig. 58 .1B-a case of ischemia secondary to embolic phenomenon in a patient with coronary artery ectasia (a condition associated with coronary aneurysm formation). Delayed enhancement may also occur with myocardial scarring-the end product of myocyte damage-in which contrast is retained within the widened interstitium between collagen fibers. Wall thickness may help distinguish enhancement of infarction from that of fibrosis: a thin enhancing wall-as seen in the left ventricular wall in the four-chamber view of the contrast-enhanced IR T1WI in Fig. 58.1C -implies chronic scarring, whereas a thick, enhancing wall signifies acute ischemia. Complications of myocardial infarction are also readily visible on MRI. The two-chamber cine image in Fig. 58.1D demonstrates an intraventricular aneurysm with wall dilatation. Although flow is present within portions of the aneurysm (black asterisk), low SI clot is also present (white asterisk). Unlike regions of scarring or ischemia, clot does not exhibit delayed enhancement on contrast-enhanced IR T1WI. Pericardium surrounding a true aneurysm (Fig. 58.1D) is less likely to enhance than that surrounding a false aneurysm. The latter consists of ruptured myocardium, its contents are enclosed by thickened pericardial adhesions. Fig. 58.1 (A-D) 
